CTI BioPharma
-$0.04 (-1.48%) Today
+$0.01 (+0.37%) As of 12:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTI BioPharma and other ETFs, options, and stocks.
About CTIC
CTI BioPharma Corp. is a biopharmaceutical company, which focuses on the development, acquisition and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis.
CEO
Adam R. Craig
Employees
23
Headquarters
Seattle, Washington
Founded
1991
CTIC Key Statistics
Market Cap
249.14M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
538.01K
High Today
$2.70
Low Today
$2.66
Open Price
$2.70
Volume
545.31K
52 Week High
$4.13
52 Week Low
$2.15
Analyst Ratings
100%
of 6 ratings
Buy
100%
Hold
0%
Sell
0%
CTIC Earnings
-$0.23
-$0.15
-$0.08
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 9, After Hours